Aimovig Global Market Report 2025

Aimovig Global Market Report 2025 – By Clinical Indication (Migraine, Cluster Headache, Other Headache Disorders), By Distribution Channel (Hospital And Clinics, Retail And Specialty Pharmacies), By End User (Adult, Geriatric) – Market Size, Trends, And Global Forecast 2025-2034

Name: Aimovig Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Aimovig Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Aimovig Market Definition

Aimovig is a therapy designed to prevent migraines by targeting the calcitonin gene-related peptide (CGRP) receptor. It works by blocking CGRP activity, a protein that contributes to the occurrence of migraines, thereby reducing their frequency and severity.

The main clinical indication for aimovig is migraine, cluster headache, other headache disorders. A migraine is a type of primary headache disorder characterized by recurrent, often severe, headaches that are typically one-sided (though they can affect both sides), and are often accompanied by other symptoms such as nausea, vomiting, and sensitivity to light, sound, or smells. These are distributed through various distribution channels such as hospital and clinics, retail and specialty pharmacies and are used by various end users such as adult, geriatric.

Aimovig Market Segmentation

The aimovigmarket covered in this report is segmented –

1) By Clinical Indication: Migraine, Cluster Headache, Other Headache Disorders

2) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies

3) By End User: Adult, Geriatric

Aimovig Market Size and growth rate 2025 to 2029: Graph

Aimovig Market Size 2025 And Growth Rate

The aimovig market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of migraine disorders, advancements in CGRP (calcitonin gene-related peptide) research, increasing demand for targeted migraine treatments, growing recognition of chronic migraine as a neurological condition, supportive regulatory approvals for migraine therapies, expanding healthcare access and infrastructure, and increased investment in biotechnology for innovative treatments.

Aimovig Market Growth Forecast

The aimovig market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing prevalence of chronic migraines, continued advancements in CGRP inhibitors, increasing adoption of Aimovig as a first-line treatment for migraine prevention, expanding clinical evidence supporting the efficacy of Aimovig, rising demand for non-daily migraine treatments, increasing healthcare investments in neurological disorders, and expanding insurance coverage for migraine therapies. Major trends in the forecast period include growing adoption of CGRP inhibitors, development of more convenient delivery methods like self-administered injections, integration of advanced monitoring technologies for personalized treatment, increasing collaborations between biotech firms and healthcare providers, rising focus on personalized migraine therapies, and expansion into emerging markets with high unmet medical needs.

Book your 30 minutes free consultation with our research experts

Aimovig Market Driver: Rising Migraine Incidence Fuels Growth Of Aimovig Market

The increasing incidence of migraine disorders is expected to propel the growth of the aimovig market going forward. Migraine, a complex neurological condition, is characterized by recurring headaches often accompanied by nausea, sensitivity to light and sound, and other symptoms. The rising incidence is due to several factors, including lifestyle changes, increasing stress levels, genetic predispositions, hormonal fluctuations (particularly in women), and greater diagnostic awareness. Aimovig, the first FDA-approved CGRP receptor blocker, is a leading treatment that addresses the unmet needs of migraine patients by offering a targeted, preventive solution. Aivimog is an innovative migraine management platform that uses advanced AI-driven algorithms to track, analyze, and predict migraine triggers, providing personalized recommendations for prevention, symptom relief, and real-time management through data-driven insights, ultimately helping migraine patients reduce the frequency, intensity, and duration of their attacks while improving their overall quality of life. For instance, in March 2024, according to the House of Commons Library, a UK-based government agency, approximately 10 million people live with migraine in the UK. Therefore, The increasing incidence of migraine disorders drives the aimovig market.

Aimovig Market Driver: Impact Of Rising Healthcare Spending On The Aimovig Market

The rise in healthcare spending is expected to propel the growth of the aimovig market going forward. Healthcare spending refers to the total financial resources allocated by individuals, governments, private insurers, and other entities towards the provision of healthcare services and products. The rise in healthcare spending is attributed to aging population, advancements in medical technology, rising prevalence of chronic diseases, and increased demand for healthcare services. Healthcare spending supports Aimovig by driving investment in innovative treatments, expanding patient access through insurance coverage, funding ongoing research and development for improved therapeutic outcomes, and promoting public health initiatives that raise awareness and enhance the overall adoption of migraine prevention therapies. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, rise in healthcare spending is driving the growth of the aimovig market.

Aimovig Market Driver: The Rise Of Personalized Medicine Fueling Growth In The Aimovig Market

Rising personalized medicine is expected to propel the growth of the aimovig market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle, to achieve the most effective and precise outcomes. The rising personalized medicine is due to advancements in genomic technologies, increased understanding of molecular biology, growing availability of precision diagnostic tools, and the demand for targeted therapies that improve patient outcomes while minimizing side effects. Aimovig, a monoclonal antibody designed to target and block the calcitonin gene-related peptide receptor, helps personalize medicine by providing an effective, tailored treatment for individuals suffering from chronic migraines, enabling healthcare providers to select the most appropriate therapy based on patient-specific factors, such as treatment history, efficacy, and tolerability, ultimately optimizing outcomes for each patient. For instance, in 2023, according to the Personalized Medicine Coalition, a US-based representative organization, in 2022, the FDA approved personalized medicines for 34% of new drugs, and during the previous eight years, they had been approved for at least 25% of new drugs. Therefore, rising personalized medicine drives the aimovig market.

Global Aimovig Market Major Players

Major companies operating in the aimovig market include Novartis AG, Amgen Inc.

Regional Outlook For The Global Aimovig Market

North America was the largest region in the aimovig market in 2024. The regions covered in the aimovig market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aimovig market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Aimovig Market?

The aimovig market consists of sales of monoclonal antibody-based therapies specifically developed to prevent migraines by inhibiting CGRP receptor activity. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Aimovig Industry?

The aimovig market research report is one of a series of new reports from The Business Research Company that provides aimovig market statistics, including aimovig industry global market size, regional shares, competitors with a aimovig market share, detailed aimovig market segments, market trends, and opportunities, and any further data you may need to thrive in the aimovig industry. This aimovig market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Aimovig Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Clinical Indication: Migraine, Cluster Headache, Other Headache Disorders 2) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies 3) By End User: Adult, Geriatric
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Novartis AG, Amgen Inc.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Aimovig Market Characteristics

3. Aimovig Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Aimovig Market Trends And Strategies

5. Aimovig Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Aimovig Growth Analysis And Strategic Analysis Framework

6.1. Global Aimovig PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Aimovig Market Growth Rate Analysis

6.4. Global Aimovig Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Aimovig Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Aimovig Total Addressable Market (TAM)

7. Global Aimovig Market Pricing Analysis & Forecasts

8. Aimovig Market Segmentation

8.1. Global Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Migraine

Cluster Headache

Other Headache Disorders

8.2. Global Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital And Clinics

Retail And Specialty Pharmacies

8.3. Global Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Geriatric

9. Global Aimovig Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Aimovig Market Regional And Country Analysis

10.1. Global Aimovig Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Aimovig Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Aimovig Market

11.1. Asia-Pacific Aimovig Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Aimovig Market

12.1. China Aimovig Market Overview

12.2. China Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Aimovig Market

13.1. India Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Aimovig Market

14.1. Japan Aimovig Market Overview

14.2. Japan Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Aimovig Market

15.1. Australia Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Aimovig Market

16.1. South Korea Aimovig Market Overview

16.2. South Korea Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Aimovig Market

17.1. Western Europe Aimovig Market Overview

17.2. Western Europe Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Aimovig Market

18.1. UK Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Aimovig Market

19.1. Germany Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Aimovig Market

20.1. France Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aimovig Market

21.1. Eastern Europe Aimovig Market Overview

21.2. Eastern Europe Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Aimovig Market

22.1. North America Aimovig Market Overview

22.2. North America Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Aimovig Market

23.1. USA Aimovig Market Overview

23.2. USA Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Aimovig Market

24.1. Canada Aimovig Market Overview

24.2. Canada Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Aimovig Market

25.1. South America Aimovig Market Overview

25.2. South America Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Aimovig Market

26.1. Middle East Aimovig Market Overview

26.2. Middle East Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Aimovig Market

27.1. Africa Aimovig Market Overview

27.2. Africa Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Aimovig Market Competitive Landscape And Company Profiles

28.1. Aimovig Market Competitive Landscape

28.2. Aimovig Market Company Profiles

28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

28.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Aimovig Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Aimovig Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Aimovig Market

32. Recent Developments In The Aimovig Market

33. Aimovig Market High Potential Countries, Segments and Strategies

33.1 Aimovig Market In 2029 - Countries Offering Most New Opportunities

33.2 Aimovig Market In 2029 - Segments Offering Most New Opportunities

33.3 Aimovig Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Aimovig Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Aimovig Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Asia-Pacific, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Japan, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Australia, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: South Korea, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Western Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: UK, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Germany, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: France, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Eastern Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: North America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: USA, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Canada, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: South America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Middle East, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Africa, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Novartis AG Financial Performance

Table 60: Amgen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Aimovig Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Aimovig Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Asia-Pacific, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Japan, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Australia, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: South Korea, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Western Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: UK, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Germany, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: France, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Eastern Europe, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: North America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: USA, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Canada, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: South America, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Middle East, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Africa, Aimovig Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Aimovig Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Aimovig Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Novartis AG Financial Performance

Figure 60: Amgen Inc. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the fertility drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the antivirals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the gastric cancer drugs market research report 2022 with industry size, share, segments and market growth

Peptide Antibiotics Global Market Report 2025 – By Type (Ribosomal Synthesized Peptide Antibiotics, Non-ribosomal Synthesized Peptide Antibiotics), By Drugs (Daptomycin, Dalbavancin, Telavancin, Other Drugs), By Disease Outlook (Skin Infection, HABP/VABP, Blood Stream Infection, Other Diseases), By Distribution Channel (Hospitals, Homecare, Specialty Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Glycopeptide Antibiotics Global Market Report 2025 – By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication (Skin And Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Other Indications), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Synthesis Global Market Report 2025 – By Product And Service (Reagents, Equipment, Services), By Technology (Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology), By End User (Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biosimilar Therapeutic Peptides Global Market Report 2025 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Therapeutics Global Market Report 2025 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Penetrating Peptide Global Market Report 2025 – By Type (Synthetic Cell Penetrating Peptides, Protein-Derived Cell Penetrating Peptides, Chimeric Cell Penetrating Peptides), By Application (Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, Other Applications), By End Use (Pharmaceutical And Biotechnology Companies, Contract Research Organization (CROs), Hospitals And Clinics, Others End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dipeptide Peptidase 4 Inhibitors Global Market Report 2025 – By Type (Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, Vildagliptin, Others Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels), By Application (Type 2 Diabetes, Gestational Diabetes, Metabolic Syndrome, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide And Oligonucleotide CDMO Global Market Report 2025 – By Product (Peptides, Oligonucleotides), By Service Type (Contract Development, Contract Manufacturing,), By Application (Therapeutics, Research Applications, Diagnostics, Other Applications), By End User (Biopharmaceutical Companies, Pharmaceutical Companies, Research Institutes, Academic and Government Organizations, Others End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Aimovig market?

How will the Aimovig market drivers and restraints affect the market dynamics? What forces will shape the Aimovig industry going forward?

The Aimovig market major growth driver - Rising Migraine Incidence Fuels Growth Of Aimovig Market. For further insights on the Aimovig market, request a sample here

What is the forecast market size or the forecast market value of the Aimovig market?

The Aimovig market size has grown strongly in recent years. The aimovig market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of migraine disorders, advancements in CGRP (calcitonin gene-related peptide) research, increasing demand for targeted migraine treatments, growing recognition of chronic migraine as a neurological condition, supportive regulatory approvals for migraine therapies, expanding healthcare access and infrastructure, and increased investment in biotechnology for innovative treatments. The aimovig market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing prevalence of chronic migraines, continued advancements in CGRP inhibitors, increasing adoption of Aimovig as a first-line treatment for migraine prevention, expanding clinical evidence supporting the efficacy of Aimovig, rising demand for non-daily migraine treatments, increasing healthcare investments in neurological disorders, and expanding insurance coverage for migraine therapies. Major trends in the forecast period include growing adoption of CGRP inhibitors, development of more convenient delivery methods like self-administered injections, integration of advanced monitoring technologies for personalized treatment, increasing collaborations between biotech firms and healthcare providers, rising focus on personalized migraine therapies, and expansion into emerging markets with high unmet medical needs. For further insights on the Aimovig market, request a sample here

How is the Aimovig market segmented?

The aimovigmarket covered in this report is segmented –
1) By Clinical Indication: Migraine; Cluster Headache; Other Headache Disorders
2) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies
3) By End User: Adult; Geriatric For further insights on the Aimovig market, request a sample here

Which region has the largest share of the Aimovig market? What are the other regions covered in the report?

Who are the major players in the Aimovig market?

Major companies operating in the aimovig market include Novartis AG, Amgen Inc. . For further insights on the Aimovig market, request a sample here.

What are the key trends in the Aimovig market?

Major trends in the Aimovig market include . For further insights on the Aimovig market, request a sample here.

What are the major opportunities in the Aimovig market? What are the strategies for the Aimovig market?

For detailed insights on the major opportunities and strategies in the Aimovig market, request a sample here.

How does the Aimovig market relate to the overall economy and other similar markets?

For detailed insights on Aimovig's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Aimovig industry?

For detailed insights on the mergers and acquisitions in the Aimovig industry, request a sample here.

What are the key dynamics influencing the Aimovig market growth? SWOT analysis of the Aimovig market.

For detailed insights on the key dynamics influencing the Aimovig market growth and SWOT analysis of the Aimovig industry, request a sample here.